Volume 110, Issue 4
Original Paper

Modeling complete removal of risk assessment questions in the USA predicts the risk of HIV exposure in blood recipients could increase despite the use of nucleic acid testing

H. Yang

Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA

Search for more papers by this author
S. A. Anderson

Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA

Search for more papers by this author
R. Forshee

Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA

Search for more papers by this author
A. Williams

Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA

Search for more papers by this author
J. S. Epstein

Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA

Search for more papers by this author
P. W. Marks

Corresponding Author

Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA

Correspondence: Peter W. Marks, Center for Biologics Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Avenue, WO71‐7230, Silver Spring, MD 20993, USA

E‐mail: peter.marks@fda.hhs.gov

Search for more papers by this author
First published: 14 January 2016
Citations: 4

Abstract

Background and Objectives

The safety of the blood supply in a number of countries is achieved by interventions that include behaviour‐based time‐limited or indefinite deferrals and screening of donated units for transfusion‐transmitted infections. The relatively high sensitivity of nucleic acid testing (NAT) used in blood donor screening has raised the question of whether such time‐based deferrals can be eliminated in favour of individual risk assessment.

Materials and Methods

Data on the annual number of incident human immunodeficiency virus (HIV) infections associated with various behaviours and on the performance characteristics of NAT applied to donor screening were used to model the number of potentially infected units that might escape detection in the worst‐case scenario in which individual risk assessment was implemented, but was not effective as a screening tool, and donors did not otherwise self‐select for lower risk.

Results

In the absence of effective individual risk‐based screening or donor self‐selection, the model predicts that in the United States, an additional 39 (95% CI 35–43) HIV‐infected units would escape detection by nucleic acid testing, potentially capable of exposing approximately 68 (95% CI 61–75) individuals to the risk of HIV infection through the administration of prepared blood components.

Conclusion

Despite some inherent uncertainty, the worst‐case scenario of completely ineffective individual risk assessment, absence of donor self‐selection and increased reliance on NAT for blood screening is estimated to be associated with an approximately fourfold increase in the risk of HIV exposure through transfusion in the United States.

Number of times cited according to CrossRef: 4

  • Proceedings of the AABB blood center executive summit, Transfusion, 10.1111/trf.16054, 60, S4, (S1-S16), (2020).
  • HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men, Blood, 10.1182/blood.2020007003, 136, 11, (1359-1367), (2020).
  • Do high‐risk behavior deferrals work? How to make it better?, Transfusion, 10.1111/trf.15409, 59, 7, (2180-2183), (2019).
  • Transition to a 1‐year deferral for male blood donors who report sexual contact with men: staff perspectives at one blood collection organization, Transfusion, 10.1111/trf.14632, 58, 8, (1909-1915), (2018).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.